Villumsen J, Alm A
Department of Ophthalmology, University Hospital, Umeå, Sweden.
Acta Ophthalmol (Copenh). 1990 Jun;68(3):341-3. doi: 10.1111/j.1755-3768.1990.tb01935.x.
Ocular hypotensive effects and side effects of two different topically applied prostaglandin (PG) esters were evaluated in a double masked study in 12 healthy males. Three doses of 15-propionat-PGF2 alpha-isopropylester (15-prop-PGF2 alpha-IE), two doses of PGF2 alpha-isopropylester (PGF2 alpha-IE), and placebo were compared. At equipotent doses 15-prop-PGF2 alpha-IE caused similar ocular side effects as PGF2 alpha-IE. It is concluded that both PGF2 alpha-IE and 15-prop-PGF2 alpha-IE reduce the IOP in normal eyes, but the use of a diester such as 15-prop-PGF2 alpha-IE does not provide a better separation between effect on IOP and side effects than PGF2 alpha-IE.
在一项针对12名健康男性的双盲研究中,评估了两种不同局部应用的前列腺素(PG)酯的降眼压作用和副作用。比较了15-丙酸-PGF2α-异丙酯(15-prop-PGF2α-IE)的三种剂量、PGF2α-异丙酯(PGF2α-IE)的两种剂量以及安慰剂。在等效剂量下,15-prop-PGF2α-IE引起的眼部副作用与PGF2α-IE相似。结论是,PGF2α-IE和15-prop-PGF2α-IE均可降低正常眼的眼压,但与PGF2α-IE相比,使用15-prop-PGF2α-IE这种二酯并不能在眼压作用和副作用之间实现更好的区分。